iCAD (ICAD) Competitors $1.54 -0.02 (-1.28%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ICAD vs. APYX, CODX, STIM, PYPD, TTOO, BWAY, DRTS, LAKE, NVRO, and KRMDShould you be buying iCAD stock or one of its competitors? The main competitors of iCAD include Apyx Medical (APYX), Co-Diagnostics (CODX), Neuronetics (STIM), PolyPid (PYPD), T2 Biosystems (TTOO), BrainsWay (BWAY), Alpha Tau Medical (DRTS), Lakeland Industries (LAKE), Nevro (NVRO), and KORU Medical Systems (KRMD). These companies are all part of the "medical equipment" industry. iCAD vs. Apyx Medical Co-Diagnostics Neuronetics PolyPid T2 Biosystems BrainsWay Alpha Tau Medical Lakeland Industries Nevro KORU Medical Systems iCAD (NASDAQ:ICAD) and Apyx Medical (NASDAQ:APYX) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, community ranking, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends. Does the MarketBeat Community favor ICAD or APYX? iCAD received 150 more outperform votes than Apyx Medical when rated by MarketBeat users. Likewise, 62.13% of users gave iCAD an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformiCADOutperform Votes22862.13% Underperform Votes13937.87% Apyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% Do analysts rate ICAD or APYX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iCAD 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Is ICAD or APYX more profitable? iCAD has a net margin of -17.81% compared to Apyx Medical's net margin of -58.59%. iCAD's return on equity of -15.65% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets iCAD-17.81% -15.65% -12.52% Apyx Medical -58.59%-137.98%-36.74% Which has more risk and volatility, ICAD or APYX? iCAD has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Does the media prefer ICAD or APYX? In the previous week, iCAD had 7 more articles in the media than Apyx Medical. MarketBeat recorded 7 mentions for iCAD and 0 mentions for Apyx Medical. iCAD's average media sentiment score of 0.48 beat Apyx Medical's score of 0.00 indicating that iCAD is being referred to more favorably in the media. Company Overall Sentiment iCAD Neutral Apyx Medical Neutral Do insiders & institutionals have more ownership in ICAD or APYX? 24.6% of iCAD shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 10.3% of iCAD shares are held by company insiders. Comparatively, 16.8% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better earnings and valuation, ICAD or APYX? iCAD has higher earnings, but lower revenue than Apyx Medical. iCAD is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiCAD$17.32M2.37-$4.85M-$0.13-11.88Apyx Medical$52.35M1.01-$18.71M-$0.83-1.69 SummaryiCAD beats Apyx Medical on 11 of the 17 factors compared between the two stocks. Ad Wyatt Investment ResearchMy #1 Pre IPO Trade for 2025 – NAME and TICKEROne tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO Get iCAD News Delivered to You Automatically Sign up to receive the latest news and ratings for ICAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICAD vs. The Competition Export to ExcelMetriciCADSurgical & medical instruments IndustryComputer SectorNASDAQ ExchangeMarket Cap$41.40M$4.47B$24.16B$8.90BDividend YieldN/A36.79%2.76%4.07%P/E Ratio-11.8813.27227.4413.46Price / Sales2.3744.833,404.1387.66Price / CashN/A52.2733.0636.27Price / Book1.395.776.796.30Net Income-$4.85M$13.76M$658.63M$225.93M7 Day Performance-13.45%-1.10%0.15%-1.32%1 Month Performance-15.11%0.56%0.71%0.60%1 Year Performance18.85%50.90%18.91%26.23% iCAD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICADiCAD0.5189 of 5 stars$1.55-1.3%N/A+16.2%$41.40M$17.32M-11.8867Analyst UpgradeAPYXApyx Medical1.4379 of 5 stars$1.40+9.4%N/A-39.1%$48.18M$52.35M-1.69270CODXCo-Diagnostics4.3727 of 5 stars$1.04-2.8%$1.50+44.2%-27.8%$34.17M$6.81M0.00100Short Interest ↓Gap DownSTIMNeuronetics2.3981 of 5 stars$0.80+6.6%$4.67+481.5%-40.6%$22.92M$71.35M0.00180PYPDPolyPid2.8681 of 5 stars$3.49-3.1%$12.00+243.8%-14.3%$17.27MN/A0.0080Positive NewsHigh Trading VolumeTTOOT2 Biosystems2.4481 of 5 stars$0.46-4.2%$5.00+982.7%-88.3%$10.16M$7.19M0.00180BWAYBrainsWay3.9884 of 5 stars$9.83+1.7%$13.17+33.9%+103.9%$161.28M$31.78M98.31120Gap UpDRTSAlpha Tau Medical2.3971 of 5 stars$2.30flat$8.00+248.6%-20.7%$160.24MN/A0.0080LAKELakeland Industries4.4003 of 5 stars$21.14-2.0%$26.50+25.4%+44.7%$159.62M$124.69M88.081,750NVRONevro2.8885 of 5 stars$4.23-0.2%$9.10+115.1%-74.5%$158.88M$425.17M-2.241,215Analyst UpgradeGap DownKRMDKORU Medical Systems2.0124 of 5 stars$3.65+10.3%$4.13+13.0%+60.1%$151.72M$28.52M0.0080 Related Companies and Tools Related Companies Apyx Medical Alternatives Co-Diagnostics Alternatives Neuronetics Alternatives PolyPid Alternatives T2 Biosystems Alternatives BrainsWay Alternatives Alpha Tau Medical Alternatives Lakeland Industries Alternatives Nevro Alternatives KORU Medical Systems Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ICAD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iCAD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iCAD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ICAD Stock Alerts